United States · FDA National Drug Code directory

EOVIST

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50419-320_21b68b8a-33ca-4b8a-9981-bb52c48674c2
Product NDC
50419-320
Form
INJECTION, SOLUTION
Composition / generic term
Gadoxetate Disodium
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Marketing category
NDA
Marketing start / end (source format)
20080703
Source listing expiry
20271231

Source-listed ingredients

  • GADOXETATE DISODIUM — 181.43 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 VIAL, SINGLE-DOSE in 1 BOX (50419-320-05) / 10 mL in 1 VIAL, SINGLE-DOSE · 50419-320-05
  • 5 VIAL, SINGLE-DOSE in 1 BOX (50419-320-15) / 15 mL in 1 VIAL, SINGLE-DOSE · 50419-320-15
  • 5 VIAL, SINGLE-DOSE in 1 BOX (50419-320-75) / 10 mL in 1 VIAL, SINGLE-DOSE · 50419-320-75

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →